Advancements in nanoparticle-based therapies for multidrug-resistant candidiasis infections: a comprehensive review

A Izadi, F Paknia, M Roostaee, SAA Mousavi… - …, 2024 - iopscience.iop.org
Candida auris, a rapidly emerging multidrug-resistant fungal pathogen, poses a global
health threat, with cases reported in over 47 countries. Conventional detection methods …

Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives

L Fernandes, R Ribeiro, M Henriques… - European Journal of …, 2022 - Springer
Nowadays, fungal infections affect millions of people across the world. Candida auris, a new
emergent yeast, is a worrisome pathogen because it associates with a high rate of incidence …

Green synthesis of antileishmanial and antifungal silver nanoparticles using corn cob xylan as a reducing and stabilizing agent

RL Silva Viana, G Pereira Fidelis… - Biomolecules, 2020 - mdpi.com
Corn cob is an agricultural byproduct that produces an estimated waste burden in the
thousands of tons annually, but it is also a good source of xylan, an important bioactive …

Curcumin nanoparticles: The topical antimycotic suspension treating oral candidiasis

SK Anwar, SNA Elmonaem, E Moussa, AG Aboulela… - Odontology, 2023 - Springer
Phytotherapeutics is widely used nowadays as an alternative to the current antifungal drugs
to reduce their side effects. Curcumin, with its wide therapeutic array as antioxidant and anti …

Anti-Biofilm Activity of Phenyllactic Acid against Clinical Isolates of Fluconazole-Resistant Candida albicans

A Maione, M Imparato, A Buonanno, F Carraturo… - Journal of Fungi, 2023 - mdpi.com
Commonly found colonizing the human microbiota, Candida albicans is a microorganism
known for its ability to cause infections, mainly in the vulvovaginal region, and is responsible …

A new humanized antibody is effective against pathogenic fungi in vitro

T Di Mambro, T Vanzolini, P Bruscolini… - Scientific Reports, 2021 - nature.com
Invasive fungal infections mainly affect patients undergoing transplantation, surgery,
neoplastic disease, immunocompromised subjects and premature infants, and cause over …

A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi

L Hu, C Sun, JM Kidd, J Han, X Fang, H Li… - Nature …, 2023 - nature.com
Proteins of the Hsp110 family are molecular chaperones that play important roles in protein
homeostasis in eukaryotes. The pathogenic fungus Candida albicans, which causes …

Herbal Products and Their Active Constituents Used Alone and in Combination with Antifungal Drugs against Drug-Resistant Candida sp.

A Herman, AP Herman - Antibiotics, 2021 - mdpi.com
Clinical isolates of Candida yeast are the most common cause of opportunistic fungal
infections resistant to certain antifungal drugs. Therefore, it is necessary to detect more …

Plant-Derived Substances in the Fight Against Infections Caused by Candida Species

I Guevara-Lora, G Bras, J Karkowska-Kuleta… - International journal of …, 2020 - mdpi.com
Yeast-like fungi from the Candida genus are predominantly harmless commensals that
colonize human skin and mucosal surfaces, but under conditions of impaired host immune …

Exploring the Antifungal Activity and Action of Saussurea costus Root Extracts against Candida albicans and Non-albicans Species

MF Soliman, YM Shetaia, AA Tayel, AM Munshi… - Antibiotics, 2022 - mdpi.com
The isolation and assessment of the active constituents in polar and non-polar crude
extracts of Saussurea costus roots as antifungal agents, against Candida albicans and non …